Post COVID Alopecia in the Indian Subcontinent: A Harbinger of Disease Severity

    October 2025 in “ Dermatology Practical & Conceptual ”
    Anshitha Vurimindi Kadudas, Tina Priscilla, Nihar B. Gala … S Subramanyam
    Studysummary In this study, researchers in India determined that 37.8% of patients experienced alopecia associated with COVID-19, particularly linked to disease severity, stressing the need for careful patient history review to guide treatment and reassurance.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on dpcj.org →
    Discuss this study in the Community →

    Research cited in this study 23

    1. A Cross-Sectional Study on Post-Coronavirus Disease Hair Loss at a Tertiary Care Hospital Dermatology practical & conceptual · 2023
    2. The Association Between Hair Loss and COVID-19: Impact on Quality of Life in Saudi Arabia Cureus · 2022
    3. Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia Cureus · 2022
    4. Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium Clinical, Cosmetic and Investigational Dermatology · 2022
    5. Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication Journal of Clinical Medicine · 2022
    6. A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation Journal of Medical Virology · 2021
    7. Characteristics of Telogen Effluvium in COVID-19 in Western Iran (2020) Anais Brasileiros De Dermatologia · 2021
    8. COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium Irish Journal of Medical Science (1971 -) · 2021
    9. Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management JAAD International · 2021
    10. Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium Journal of The American Academy of Dermatology · 2021
    11. Long-Term Post-COVID Symptoms and Associated Risk Factors in Previously Hospitalized Patients: A Multicenter Study Journal of infection/˜The œJournal of infection · 2021
    12. Post Covid-19 Telogen Effluvium: What Is the Reason? InterConf · 2021
    13. Telogen Effluvium Associated with COVID-19 Infection Dermatologic Therapy · 2021
    14. What Can Hair Tell Us About COVID-19? Experimental Dermatology · 2020
    15. Telogen Effluvium: A Sequela of COVID-19 International Journal of Dermatology · 2020
    16. SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study Journal of the European Academy of Dermatology and Venereology · 2020
    17. Post-Discharge Persistent Symptoms and Health-Related Quality of Life After Hospitalization for COVID-19 Journal of Infection · 2020
    18. Relative Changes in the Pattern of Diseases Presenting in Dermatology Outpatient Clinic in the Era of the COVID-19 Pandemic Dermatologic Therapy · 2020
    19. Evaluation of the Effects of COVID-19 Pandemic on Hair Diseases Through a Web-Based Questionnaire Dermatologic Therapy · 2020
    20. Management of Telogen Effluvium During the COVID-19 Emergency: Psychological Implications Dermatologic Therapy · 2020
    21. Covid-19 And Dermatology: A Comprehensive Guide For Dermatologists Journal of the European Academy of Dermatology and Venereology · 2020
    22. Telogen Effluvium: A Comprehensive Review Clinical, Cosmetic and Investigational Dermatology · 2019
    23. Dengue-Associated Telogen Effluvium: A Report of 14 Patients Dermatologica Sinica · 2017